Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Molecular Endocrinology

• Publication date

  1998-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/MEND.12.4.0088PMID 9544992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of breast cancer cell growth by steroids and growth factors: Interactions and mechanisms

  2004cited by this paper
• Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

  1997cited by this paper
• The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.

  1997cited by this paper
• Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family.

  1996cited by this paper
• Transforming growth factor-beta1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression.

  1996cited by this paper
• Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

  1996cited by this paper
• The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.

  1996cited by this paper
• Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

  1996cited by this paper
• Transforming Growth Factor-β1 Inhibits Human Keratinocyte Proliferation by Upregulation of a Receptor-Type Tyrosine Phosphatase R-PTP-κ Gene Expression

  1996cited by this paper
• Fas expression and function in normal and malignant breast cell lines.

  1996cited by this paper
• Growth factors in breast cancer.

  1995cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• The Fas death factor

  1995cited by this paper
• The LAR transmembrane protein tyrosine phosphatase and a coiled‐coil LAR‐interacting protein co‐localize at focal adhesions.

  1995cited by this paper
• FAP-1: a protein tyrosine phosphatase that associates with Fas.

  1995cited by this paper
• Insulin Receptor Signaling Is Augmented by Antisense Inhibition of the Protein Tyrosine Phosphatase LAR (*)

  1995cited by this paper
• Homophilic Interactions Mediated by Receptor Tyrosine Phosphatases μ and κ. A CRITICAL ROLE FOR THE NOVEL EXTRACELLULAR MAM DOMAIN (*)

  1995cited by this paper
• 'Zip codes' direct intracellular protein tyrosine phosphatases to the correct cellular 'address'.

  1994cited by this paper
• Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.

  1994cited by this paper
• Molecular cloning of a novel protein‐tyrosine phosphatase containing a membrane‐binding domain and GLGF repeats

  1994cited by this paper
• A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases.

  1994cited by this paper
• Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells.

  1994influential reference
• Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation.

  1994cited by this paper
• Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

  1994cited by this paper
• Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins.

  1994cited by this paper
• Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosine-phosphatase 1C in HL-60 cells.

  1994cited by this paper
• Differential activities of protein tyrosine phosphatases in intact cells.

  1993cited by this paper
• Receptor protein tyrosine phosphatase alpha activates pp60c‐src and is involved in neuronal differentiation.

  1993cited by this paper
• Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis.

  1993influential reference
• Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor-1.

  1992cited by this paper
• Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase

  1992cited by this paper
• Protein tyrosine phosphatase activation during nerve growth factor-induced neuronal differentiation of PC12 cells.

  1992cited by this paper
• Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.

  1992cited by this paper
• Expression of the receptor‐linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM‐like extracellular region.

  1992cited by this paper
• p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast.

  1991cited by this paper
• Activation of transcription via AP-1 or CREB regulatory sites is blocked by protein tyrosine phosphatases.

  1991cited by this paper
• Computer-aided quantification of RNA levels detected by in situ hybridization of tissue sections.

  1991cited by this paper
• Structural diversity and evolution of human receptor‐like protein tyrosine phosphatases.

  1990cited by this paper
• Anti-steroidal and anti-growth factor activities of anti-estrogens.

  1990cited by this paper
• Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.

  1990cited by this paper
• Antiestrogens antagonize the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture.

  1989cited by this paper
• Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase.

  1989cited by this paper
• A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila.

  1989cited by this paper
• A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen

  1988cited by this paper
• Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.

  1988cited by this paper
• Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.

  1987cited by this paper
• Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens.

  1987cited by this paper
• Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

  1984cited by this paper
• Epidermal growth factor stimulation of human breast cancer cells in culture.

  1980influential reference
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

  1958cited by this paper

• PTPN13 Participates in the Regulation of Epithelial–Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells

  2023cites this paper
• Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway.

  2020cites this paper
• PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness

  2020cites this paper
• Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer

  2020cites this paper
• High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome

  2017cites this paper
• Identification of Collective Motion Networks in the Second PDZ Domain of Human Tyrosine Phosphatase 1E

  2017cites this paper
• Régulation de l'agressivité tumorale mammaire par la protéine tyrosine phosphatase PTPL1/PTPN13

  2016cites this paper
• Protein Tyrosine Phosphatases in Cancer

  2016cites this paper
• Non-transmembrane PTPs in Cancer

  2016cites this paper
• Understanding the functions of the novel oncogene SHON in breast cancer

  2015cites this paper
• Patients following Treatment with Recombinant Erythropoietin: A Randomized Prospective Study1

  2014cites this paper
• The Wedelolactone Derivative Inhibits Estrogen Receptor-Mediated Breast, Endometrial, and Ovarian Cancer Cells Growth

  2014cites this paper
• Protein tyrosine phosphatases as novel targets in breast cancer therapy.

  2013cites this paper
• The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.

  2012cites this paper
• PTPN13/PTPL1: an important regulator of tumor aggressiveness.

  2011cites this paper
• Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes

  2011cites this paper
• PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

  2010cites this paper
• THE PUTATIVE TUMOUR SUPPRESSOR GENE PTPN13/PTPL1 INDUCES APOPTOSIS THROUGH IRS-1 DEPHOSPHORYLATION.

  2010cites this paper
• Protein tyrosine phosphatases and cancer

  2009cites this paper
• Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer

  2009cites this paper
• PTPL1: a large phosphatase with a split personality

  2008cites this paper
• The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.

  2007cites this paper
• Protein tyrosine phosphatases, new targets for cancer therapy.

  2006cites this paper
• An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors

  2006cites this paper
• Anti-growth factor activities of benzothiophenes in human breast cancer cells.

  2005cites this paper
• PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis

  2005cites this paper
• Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray

  2005cites this paper
• [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers].

  2004cites this paper
• Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

  2004cites this paper
• Keratinocyte growth factor-induced motility of breast cancer cells

  2004cites this paper
• Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer

  2004cites this paper
• Effects of hormone therapy on insulin signaling proteins in skeletal muscle of cynomolgus monkeys.

  2004cites this paper
• Evidence for a link between IGF-I and cancer.

  2004cites this paper
• Protein tyrosine phosphatases and breast cancer.

  2004cites this paper
• Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.

  2004cites this paper
• Function of the IGF-I Receptor in Breast Cancer

  2004cites this paper
• Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate

  2003cites this paper
• Expression of the Insulin-like Growth Factor-I Receptor in Primary Breast Cancer and Lymph Node Metastases: Correlations with Estrogen Receptors α and β

  2003cites this paper
• Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.

  2003cites this paper
• Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.

  2003cites this paper
• Protein-tyrosine Phosphatase PTPL1/FAP-1 Triggers Apoptosis in Human Breast Cancer Cells*

  2002cites this paper
• Solution structure of the PDZ2 domain from cytosolic human phosphatase hPTP1E complexed with a peptide reveals contribution of the beta2-beta3 loop to PDZ domain-ligand interactions.

  2002cites this paper
• Keratinocyte growth factor stimulates the migration and proliferation of breast cancer cells in a culture wounding model.

  2002cites this paper
• Effect of treatment with different doses of 17-beta-estradiol on insulin receptor substrate-1.

  2001cites this paper
• Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

  2001cites this paper
• Growth Factor-mediated Signaling and Growth-negative MCF-7 Cells Restores both Estrogen and Insulin-like α in Estrogen Receptor α Re-expression of Estrogen Receptor Updated

  2001cites this paper
• Mapping and identification of protein‐protein interactions by two‐dimensional far‐Western immunoblotting

  2000cites this paper
• Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway.

  2000cites this paper
• Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

  2000cites this paper
• PTP LAR Expression Compared to Prognostic Indices in Metastatic and Non-Metastatic Breast Cancer

  2000cites this paper
• Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer

  2000cites this paper
• The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

  2000cites this paper
• Phosphorylation-Based signaling in Fas receptor-mediated apoptosis.

  2000cites this paper
• Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

  1999cites this paper
• Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

  1999influential citation
• Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

  1999cites this paper
• Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics

  1999cites this paper
• Differential Expression of Estrogen Receptor-α and -β Messenger RNAs as a Potential Marker of Ovarian Carcinogenesis

  1998cites this paper
• Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

  1998cites this paper